General Atlantic-backed Royalty Pharma makes big IPO splash

General Atlantic invested approximately $415m in the biopharma royalty giant in Feburary, according to a source familiar with the matter.

17 June 2020•3 mins read
VCJ IPO Profiles Venture
LinkedInXEmail
LinkedInXEmail

Related articles